Laxative

Product NDC
41163-625
11-digit product format
411630625
Labeler code
41163
Product ID
41163-625_ed870c3a-4570-449b-9629-7ad20b52b5a6
Type
HUMAN OTC DRUG
Nonproprietary name
Sennosides
Dosage form
TABLET, CHEWABLE
Route
ORAL
Labeler
Supervalu Inc.
Application
part334
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2021-02-24
Marketing end
0000-00-00
Substance
SENNOSIDES
Active strength
15 mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct41163-625IInactivated by FDA2026-10-15
excluded packagepackage41163-62541163-625-18IInactivated by FDA2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductIInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage41163-625-18IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductIInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage41163-625-18IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductIInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage41163-625-18IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductIInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage41163-625-18IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductIInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage41163-625-18IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductIInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage41163-625-18IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductUExcluded because listing certification expired302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage41163-625-18UExcluded because listing certification expired302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductUExcluded because listing certification expireded331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage41163-625-18UExcluded because listing certification expireded331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductUExcluded because listing certification expired0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage41163-625-18UExcluded because listing certification expired0efc9e666f02…f202fb6c5f17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
41163-625-182025-01-30C16284748780-1f386c649-cf49-0266-e053-dadaa90a7c1aDrug Facts
41163-625-182023-02-10C16284748780-1f386c649-cf49-0266-e053-dadaa90a7c1aDrug Facts
41163-625-182023-01-30C16284748780-1f386c649-cf49-0266-e053-dadaa90a7c1aDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
41163-625-18Laxative Regular Strength, chocolated stimulant laxative sennosides, Equaline2 in 1 CARTONTABLET, CHEWABLE22
41163-625-18Laxative Regular Strength, chocolated stimulant laxative sennosides, Equaline9 in 1 POUCHTABLET, CHEWABLE92

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
41163-625-18EA - Each41163-62523c6bd3c-f299-48a8-90c2-821a71b7ae3912021-03-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
41163-625LAXATIVE REGULAR STRENGTH, CHOCOLATED STIMULANT LAXATIVE SENNOSIDES, EQUALINE (SENNOSIDES) TABLET, CHEWABLE [SUPERVALU INC.]2Legacy NDC, 2 package rows20230211_702750a7-463e-43bc-bdf6-eeebcd434d0b.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
251020sennosides 15 MG Chewable TabletPSN702750a7-463e-43bc-bdf6-eeebcd434d0b2
251020sennosides, USP 15 MG Chewable TabletSCD702750a7-463e-43bc-bdf6-eeebcd434d0b2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
41163-625-18411630625182 POUCH in 1 CARTON (41163-625-18) > 9 TABLET, CHEWABLE in 1 POUCH2 pouch2021-02-240000-00-00NoNoCurrent